Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 76.73

+1.7%

4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1160)	6/27/2005 10:43:29 AM
From: Jibacoa	Read Replies (1) of 3722

KOSN Tested again support at 4.98 on Friday and is trying to stay above the $5 level today The near term uptrend that started on June 16 from the 4.45 level is still intact, but would be broken if the stock can't hold above 4.95 <g> bigcharts.marketwatch.com The revenues in the March Q were less than half of the 1st Q in 2004 (2.9M vs. 6.4M) and the loss was also double ($0.28/shr vs. $0.14) as it also increased somewhat on a sequential basis.For 2005 the EL is around $1.11/shr vs. $0.77 in 2004 KOSN reportedly has around $2.13 in cash/shr a Debt/Equt around 0.07 and BV around 2.11 On June 6 it announced that it had initiated a PI of its KOS-1022 in patients with hematologic malignancies and that the U.S. PTO had granted it a patent covering the KOS-1022 and its use for treating a range of cancers. Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next